期刊文献+

ATP1A1在结肠腺癌组织中的表达及其与临床病理特征和预后的关系

Expression of ATP1A1 in the colonic adenocarcinoma and its relationship with clinicopathological characteristics and prognosis
下载PDF
导出
摘要 目的探讨Na^(+)/K^(+)转运ATP酶α亚单位1(ATP1A1)在结肠腺癌(COAD)组织中的表达及其与COAD患者临床病理特征和预后的关系。方法实时荧光定量PCR检测ATP1A1在COAD组织和配对的癌旁组织中的表达,分析ATP1A1在COAD组织中的表达与患者临床病理特征和预后的相关性。结果与癌旁组织(5.70±5.87)相比,ATP1A1在COAD组织中的表达显著降低(2.96±3.98,t=4.966,P<0.001)。COAD组织中ATP1A1的表达与肿瘤大小(χ^(2)=5.537,P=0.019)、浸润深度(χ^(2)=5.326,P=0.021)和远处转移有关(χ^(2)=5.103,P=0.024)。ATP1A1低表达组COAD患者的中位生存时间(42.062个月)显著低于ATP1A1高表达组COAD患者(52.099个月,χ^(2)=9.954,P=0.002)。多因素COX回归模型分析表明,ATP1A1是COAD患者的独立预后因素,低表达ATP1A1预示着COAD患者的较差预后。结论ATP1A1在COAD组织中表达降低,与患者的预后密切相关,是COAD预后预测及治疗的潜在靶点。 Objective To investigate the expression of ATPase Na^(+)/K^(+) transporting subunit alpha 1(ATP1A1)in colonic adenocarcinoma(COAD),and to explore the relationship of ATP1A1 expression with clinicopathological characteristics and prognosis.Methods Quantitative real-time PCR was used to test the expression of ATP1A1 in the paired COAD and adjacent normal tissues.The associations of ATP1A1 expression with clinicopathological characteristics were evaluated.The prognostic value of ATP1A1 in the COAD patients were determined.Results The ATP1A1 expression was down-regulated in the COAD tissues compared with paired adjacent noncancerous tissues(2.96±3.98 and 5.70±5.87,t=4.966,P<0.001)and was related with tumor size(χ^(2)=5.537,P=0.019),T stage(χ^(2)=5.326,P=0.021)and distant metastasis(χ^(2)=5.103,P=0.024).The COAD patients with low ATP1A1 expression were associated with poorer overall survival compared to those with high ATP1A1 expression(42.062 months and 52.099 months,χ^(2)=9.954,P=0.002).COX analyses showed that low expression of ATP1A1 was an independent predictor for poor prognosis in COAD patients.Conclusion ATP1A1 expression was deceased in COAD,which presented a potential biomarker for poor prognosis of COAD patients and represented a possible molecular target for the treatment of COAD.
作者 韩娜 张彦彦 张中冕 张芳 张相 赵文超 HAN Na;ZHANG Yanyan;ZHANG Zhongmian;ZHANG Fang;ZHANG Xiang;ZHAO Wenchao(Department of Oncology,the Second Affiliated Hospital of Zhengzhou University,Zhengzhou 450014,China;Department of Physiology and Neurobiology,School of Basic Medical Sciences,Zhengzhou University,Zhengzhou 450001,China)
出处 《肿瘤基础与临床》 2021年第6期475-478,共4页 journal of basic and clinical oncology
基金 河南省重点研发与推广专项项目(202102310099) 郑州大学第二附属医院科技创新人才培育基金资助项目(2020BJRCB04)。
关键词 Na^(+)/K^(+)转运ATPα亚单位1 结肠腺癌 预后 ATPase Na^(+)/K^(+)transporting subunit alpha 1 colonic adenocarcinoma prognosis
  • 相关文献

参考文献5

二级参考文献46

  • 1强金虎.中性粒细胞与淋巴细胞比值评估老年结肠癌患者预后的影响观察[J].世界最新医学信息文摘,2019,0(95):206-207. 被引量:1
  • 2窦春青,岳鑫,周宁新.hFXYD6反义核酸对胆管癌细胞体外增殖和侵袭能力的影响[J].世界华人消化杂志,2007,15(9):929-935. 被引量:8
  • 3黄秋实,史成章,王红建,秦先锋.maspin及uPA在结肠癌组织中的表达及其临床意义[J].肿瘤基础与临床,2007,20(3):219-221. 被引量:7
  • 4Rajasekaran SA, P.ajasekaran AK. Na, K ATPasc and epithelial tight junctions[J]. Front Biosci, 2009, 14 : 130-148.
  • 5Rajasekaran SA, Huynh TP, Wolle DG, et al. Na, K-ATPase subunits as markers for epithelial-nmsenchymal transition in cancerand fibrosis [J]. Mol Cancer Ther, 2010, 9 ( 6 ) : 1515-1524.
  • 6Zhang L, Zhang Z, Guo H, et al. Na +/K +-ATPase-mediated signal transduction and Na ^+/K ^+ ATPase regulation[J]. Fundam Clin Pharmacol, 2008, 22(6) :615-621.
  • 7Chen JQ, Contreras RG, Wang R, et al. Sodium/potasium ATPase (Na^+ , K + -ATPase) and ouabain/related cardiac glyco- sides: a new paradigm for developnent of anti breast cancer drugs [J]. Breast Cancer lKes Treat, 2006, 96(1 ) :1-15.
  • 8Sweadner KJ, Rael E. The FXYD gene family of small ion transport regulators or channels: cDNA sequence, protein signature se- quence, and expression[J]. Genomics, 2000, 68 ( 1 ) : 41-56.
  • 9Geering K. FXYD proteins: New regulators ofNa-K ATPase[J]. Am J Physiol Renal Physiol, 2006, 290: F241-250.
  • 10Franzin CM, YuJ, Thai K, et al, Correlation of'gene and protein structures in the FXYD family proteins[J], j Mol Biol, 2005, 354(4) :743-750.

共引文献589

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部